Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.
Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute have developed new AI tools tailored to digital pathology, a growing field that uses high-resolution digital images created from tissue samples to help diagnose disease.
Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Professors Tashara M. Leak and Aditya Vashistha are recipients of the Faculty Award for Excellence in Research, Teaching and Service through Diversity.
A multinational team led by Weill Cornell Medicine investigators developed a test for an HIV strain that disproportionately affects women and will benefit patients around the world.
Designed to provide corporate leaders with critical skills and actionable insights to bring to their boardrooms, the 2024 Cornell Tech Board of Directors Forum is slated for Oct. 29 and 30 in New York City.
Cornell inventors are turning visionary ideas into tangible solutions to global challenges. Cornell’s Center for Technology Licensing celebrated their achievements at its inaugural Bearers of Innovation event.
